Did You Know...
...In 1790, the cost to obtain a patent was between $4 and $5.
PatentStorm News
Make the Most of Our Site
See this month's Top Inventors and Most Cited Patents.
Stay on top of the latest innovations by subscribing to an RSS feed.
Registered users: Manage your profile.
| Number | Title | Issue Date |
| 8178662 | Isolated AEBP1 genomic polynucleotide fragments from chromosome 7 and their uses The invention is directed to isolated genomic polynucleotide fragments that encode human SNARE YKT6, human glucokinase, human adipocyte enhancer binding protein (AEBP1) and DNA directed 50 kD regulatory subunit (POLD2), vectors and hosts containing these fragments a... | 05/15/2012 |
| 8110196 | Methods and compositions for polytopic vaccination The present invention relates to therapeutic and prophylactic methods for treating or preventing an infectious disease in a subject by stimulating or enhancing an immune response against an infectious agent causing the disease. The methods comprise administering to ... | 02/07/2012 |
| 8058052 | Isolated genomic polynucleotide fragments from chromosome 12 that encode human carboxypeptidse M The invention is directed to isolated genomic polynucleotide fragments that encode human carboxypeptidase M and human mouse double minute 2 homolog, vectors and hosts containing these fragments and fragments hybridizing to noncoding regions as well as antisense olig... | 11/15/2011 |
| 8057998 | Isolated genomic polynucleotide fragments from chromosome 19 that encode human syntaxin The invention is directed to isolated genomic polynucleotide fragments that encode human resistin and human syntaxin binding protein 2, vectors and hosts containing these fragments and fragments hybridizing to noncoding regions as well as antisense oligonucleotides ... | 11/15/2011 |
| 8053195 | Isolated genomic nucleic acid molecules obtainable from chromosome 1p21-p13 that encode human RhoC The invention is directed to an isolated genomic nucleic acid molecule fragment that encodes human RhoC, vectors and hosts containing the fragment and fragments hybridizing to noncoding regions as well as antisense oligonucleotides to these fragments. The invention ... | 11/08/2011 |
| 8039602 | Isolated genomic polynucleotide fragments from the p15 region of chromosome 11 The invention is directed to isolated genomic polynucleotide fragments from the p15 arm of chromosome 11. ... | 10/18/2011 |
| 8012687 | Isolated genomic polynucleotide fragments from chromosome 19 that encode human resistin and the human syntaxin binding protein 2 The invention is directed to isolated genomic polynucleotide fragments that encode human resistin and human syntaxin binding protein 2, vectors and hosts containing these fragments and fragments hybridizing to noncoding regions as well as antisense oligonucleotides ... | 09/06/2011 |
| 7985571 | Isolated genomic polynucleotide fragments from chromosome 17 that encode human carboxypeptidase D The invention is directed to isolated genomic polynucleotide fragments that encode human carboxypeptidase D, vectors and hosts containing the fragment and fragments hybridizing to noncoding regions as well as antisense oligonucleotides to these fragments. The invent... | 07/26/2011 |
| 7964357 | Isolated genomic polynucleotide fragments from chromosome 12 that encode human mouse double minute 2 homolog The invention is directed to isolated genomic polynucleotide fragments that encode human carboxypeptidase M and human mouse double minute 2 homolog, vectors and hosts containing these fragments and fragments hybridizing to noncoding regions as well as antisense olig... | 06/21/2011 |
| 7786280 | Isolated genomic polynucleotide fragments from chromosome 10q25.3 that encode human soluble aminopeptidase P The invention is directed to an isolated genomic polynucleotide fragment that encodes human soluble (cytosolic) aminopeptidase P, vectors and hosts containing the fragment and fragments hybridizing to noncoding regions as well as antisense oligonucleotides to these ... | 08/31/2010 |
| 7754424 | Isolated genomic polynucleotide fragments from chromosome 12 that encode human carboxypeptidase M and the human mouse double minute 2 homolog The invention is directed to isolated genomic polynucleotide fragments that encode human carboxypeptidase M and human mouse double minute 2 homolog, vectors and hosts containing these fragments and fragments hybridizing to noncoding regions as well as antisense olig... | 07/13/2010 |
| 7713528 | Method for in vivo delivery of active compounds using reagent conjugate This invention relates to novel reagent conjugates and a novel multi-step process for delivering active compounds to target analytes of interest in a patient for diagnostic and therapeutic purposes. According to the process, two novel reagents are bound to each othe... | 05/11/2010 |
| 7622478 | 1-nitroacridine/tumor inhibitor compositions The invention is directed to 1-nitroacridine derivative(s)/tumor inhibitor(s) compositions as well as methods for using said compositions for inhibiting or preventing tumor growth, particularly, prostate cancer cell growth and metastases. ... | 11/24/2009 |
| 7588915 | Isolated genomic polynucleotide fragments from chromosome 7 The invention is directed to isolated genomic polynucleotide fragments that encode human SNARE YKT6, human glucokinase, human adipocyte enhancer binding protein (AEBP1) and DNA directed 50 kD regulatory subunit (POLD2), vectors and hosts containing these fragments a... | 09/15/2009 |
| 7060502 | Method of diagnosing the chances of pregnancy and the diagnostic kit for the same Disclosed is a method of diagnosing the chances of pregnancy and the diagnostic kit for the method. In the present invention, follicular fluid is retrieved from the women who attended the in vitro fertilization program and matrix metalloproteinase activity is measur... | 06/13/2006 |
| 7495088 | Modified nucleotide compounds Disclosed is a nuclease resistant nucleotide compound capable of hybridizing with a complementary RNA in a manner which inhibits the function thereof, which modified nucleotide compound includes at least one component selected from the group consisting of MN3 | 02/24/2009 |
| 7470522 | Isolated genomic polynucleotide fragments encoding human resistin and the human syntaxin binding protein 2 The invention is directed to isolated genomic polynucleotide fragments that encode human resistin and human syntaxin binding protein 2, vectors and hosts containing these fragments and fragments hybridizing to noncoding regions as well as antisense oligonucleotides ... | 12/30/2008 |
| 7468266 | Isolated genomic polynucleotide fragments that encode human lipoprotein-associated phospholipase A2 The invention is directed to isolated genomic polynucleotide fragments that encode human lipoprotein-associated phospholipase A2, vectors and hosts containing the fragment and fragments hybridizing to noncoding regions as well as antisense oligonucleotides to these ... | 12/23/2008 |
| 7338811 | Integrated circuit chip for bioassays The invention is directed to novel IC chips containing substances used particularly in bioassays. Furthermore, the invention is directed to assay methods and kits using these chips. ... | 03/04/2008 |
| D552248 | Pacifier storage assembly | 10/02/2007 |
| 7273718 | Isolated genomic polynucleotide fragments from chromosome 10q25.3 that encode human soluble aminopeptidase P The invention is directed to an isolated genomic polynucleotide fragment that encodes human soluble (cytosolic) aminopeptidase P, vectors and hosts containing the fragment and fragments hybridizing to noncoding regions as well as antisense oligonucleotides to these ... | 09/25/2007 |
| 7198895 | In vitro cell-based methods for biological validation and pharmacological screening of chemical entities and biologicals This patent describes a novel in vitro cell-based method for biological validation and pharmacological screening of drugs, new chemical entities (NCEs) and biologics, which is predictive of in vivo testing for efficacy and adverse events in patients, as occurs in cl... | 04/03/2007 |
| D533286 | Tile base | 12/05/2006 |
| 7083812 | Chemical library preparation method from natural product The present invention relates to a preparation method of a general library and a focused library from crude extracts of natural products including herbal drugs, said libraries, and the method for developing new drugs such as an anticancer drug and new substances usi... | 08/01/2006 |
| D522149 | Tile base | 05/30/2006 |
| D505469 | Roller sled | 05/24/2005 |
| 6860339 | Bit striking apparatus for use in an excavator Disclosed is a bit striking apparatus in an excavator capable of efficiently striking the entire area of the hammer bit under uniform pressure without exerting excessive load to the excavator so that the hammer bit may be free from damage owing to local concentratio... | 03/01/2005 |
| 6764600 | Lagoon for hog waste and the method of treatment thereof The present invention relates to a lagoon partitioned for hog waste treatment, and the method of waste treatment in said lagoon. More particularly, the present invention relates to a lagoon for hog waste, which is partitioned into zones separated by walls, comprisin... | 07/20/2004 |
| D489785 | Ribbon discharger for celebration use | 05/11/2004 |
| 6692544 | Municipal waste briquetting system and method of filling land Mechanically and biologically stable briquettes and pellets are obtained from either municipal solid waste (MSW), Refuse Derived Fuel (RDF) or municipal sewage sludge and their combination for purposes of disposing said briquettes and pellets as fuel in w... | 02/17/2004 |
| 6626845 | Method and apparatus for measurement of in vivo air volumes This invention relates to instruments, particularly medical and research instruments that are used for assessing gas volumes of cavities, particularly, cavities that may exhibit a compliance to changes in pressure, such as in vivo volumes of the lung, tho... | 09/30/2003 |
| 6589961 | 9-alkylamino-1-nitroacridine derivatives The invention is directed to novel 9-hydroxyalkylamino-, 9-alkoxyalkylamino-1-nitroacridine derivatives. Methods of preparation, pharmaceutical compositions comprising said derivatives and their medical uses are also encompassed by this invention.... | 07/08/2003 |
| 6524851 | Hybrid nucleic acid molecules and vectors including ଲ-globin regulatory elements The invention relates to hybrid nucleic acid molecules for gene therapy in cells of the erythroid lineage, and in particular -, ଲ-, δ-, &3xb5;, γ-, or .zeta.-globin nucleotide sequences operably linked to ଲ-globin regulatory elements.... | 02/25/2003 |
| 6492334 | Tri-compound analgesic for treating inflammation and pain A composition of an analgesic choline bitartrate, and myo-inositol and method for using same are described herein. The composition alleviates inflammation and pain due to such causes as sciatica, injury, trauma and arthritis without the negative side effect ... | 12/10/2002 |
| 6427613 | Lawn shaker The present invention is directed to a lightweight easy to use lawn shaker that can be used for aerating the lawn and distributing dry lawn improvement substances such as grass seed, weed killer, fertilizer and dry pesticides. These substances are easily ... | 08/06/2002 |
| 6399349 | Human aminopeptidase P gene Disclosed are the human aminopeptidase P cDNA and genomic DNA. Also disclosed is the human aminopeptidase P protein and antibodies reactive with human aminopeptidase P. These molecules, and derivatives of these molecules, are useful for assay for detectin... | 06/04/2002 |
| 6311683 | Device for assembling and disassembling gas rifle and gas tank to and from each other Disclosed is a device for assembling and disassembling a gas rifle and a gas tank to and from each other, respectively. The device comprises a gas tank having a rear cap which has an adjusting valve for adjusting a gas discharging amount and a one-touch t... | 11/06/2001 |
| 5955281 | Identification of ligands by selective amplification of cells transfected with receptors The invention is directed to a method for identifying substances acting as ligands for transfected receptors by using transfected markers to measure receptor/ligand interactions.... | 09/21/1999 |
| 5912132 | Identification of ligands by selective amplification of cells transfected with receptors The invention is directed to a method for identifying substances acting as ligands for transfected receptors by using transfected markers to measure receptor/ligand interactions.... | 06/15/1999 |
